News

Eli Lilly stock gets a rare downgrade: what is HSBC concerned about?
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
Asianet Newsable on MSN1h
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm received approval from the Thai FDA in 2023.
Novo Nordisk's obesity drug Wegovy debuts in Thailand
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Devdiscourse4h
Novo Nordisk's Wegovy Makes a Splash in Thailand's Weight-Loss Market
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
Weight-loss craze sparks a DC lobbying bonanza
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...